Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment Definitions
1.2. Estimates and Forecast Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.4.5. Details of Primary Research
1.4.6. Research Assumption
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Data Visualization
1.7. Model Details
1.7.1. Volume Price Analysis
1.8. Objectives
1.9. List of Secondary Sources
1.10. List of Abbreviations
Chapter 2. Executive Summary
2.1. U.S. Ketamine Clinics Market
2.1.1. Market Snapshot
2.1.2. Segment Snapshot
2.1.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Growing demand for effective mental health treatments
3.3.1.2. Growing acceptance of ketamine’s therapeutic potential
3.3.1.3. Increasing investment and partnerships in ketamine clinics
3.3.2. Market Restraint Analysis
3.3.2.1. Potential side effects and risks associated with ketamine therapy
3.3.2.2. Easy accessibility for alternative treatments
3.4. Regulatory Framework
3.5. Business Environment Analysis Tools
3.5.1. Industry Analysis - Porter’s Five Forces Analysis
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
Chapter 4. Treatment Business Analysis
4.1. U.S. Ketamine Clinics Market: Treatment Movement Analysis
4.2. U.S. Ketamine Clinics Market: Treatment Segment Dashboard
4.3. Treatment Movement & Market Share Analysis, 2023 & 2030
4.4. U.S. Ketamine Clinics Market Estimates & Forecast, by Treatment
4.5. Depression
4.5.1. Depression market, 2018 - 2030 (USD Million)
4.6. Anxiety
4.6.1. Anxiety market, 2018 - 2030 (USD Million)
4.7. PTSD
4.7.1. PTSD market, 2018 - 2030 (USD Million)
4.8. Others
4.8.1. Others market, 2018 - 2030 (USD Million)
Chapter 5. Therapy Business Analysis
5.1. U.S. Ketamine Clinics Market: Therapy Movement Analysis
5.2. U.S. Ketamine Clinics Market: Therapy Segment Dashboard
5.3. Therapy Movement & Market Share Analysis, 2023 & 2030
5.4. U.S. Ketamine Clinics Market Estimates & Forecast, by Therapy
5.5. On-site Therapy
5.5.1. On-site therapy market, 2018 - 2030 (USD Million)
5.6. Online Therapy
5.6.1. Online therapy market, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Company Categorization
6.2. Company Market Position Analysis
6.3. Strategy Mapping
6.3.1. Partnership/Collaboration/Alliance
6.3.2. New Service Launch
6.3.3. Mergers & Acquisitions
6.3.4. Others
6.4. Company Profiles/Listing
6.4.1. NY Ketamine Infusions
6.4.1.1. Overview
6.4.1.2. Financial performance
6.4.1.3. Service benchmarking
6.4.1.4. Strategic initiatives
6.4.2. Stella MSO LLC dba Field Trip Health
6.4.2.1. Overview
6.4.2.2. Financial performance
6.4.2.3. Service benchmarking
6.4.2.4. Strategic initiatives
6.4.3. Ketamine Clinics Los Angeles
6.4.3.1. Overview
6.4.3.2. Financial performance
6.4.3.3. Service benchmarking
6.4.3.4. Strategic initiatives
6.4.4. Klarity Clinic (Tebra Inc.)
6.4.4.1. Overview
6.4.4.2. Financial performance
6.4.4.3. Service benchmarking
6.4.4.4. Strategic initiatives
6.4.5. Vitalitas Denver Ketamine Infusion Center
6.4.5.1. Overview
6.4.5.2. Financial performance
6.4.5.3. Service benchmarking
6.4.5.4. Strategic initiatives
6.4.6. Mindbloom, Inc.
6.4.6.1. Overview
6.4.6.2. Financial performance
6.4.6.3. Service benchmarking
6.4.6.4. Strategic initiatives
6.4.7. Nue Life Health (NueCo Holdings, P.B.C.)
6.4.7.1. Overview
6.4.7.2. Financial performance
6.4.7.3. Service benchmarking
6.4.7.4. Strategic initiatives
6.4.8. Better U, Inc.
6.4.8.1. Overview
6.4.8.2. Financial performance
6.4.8.3. Service benchmarking
6.4.8.4. Strategic initiatives
6.4.9. Innerwell (KBS, Inc.)
6.4.9.1. Overview
6.4.9.2. Financial performance
6.4.9.3. Service benchmarking
6.4.9.4. Strategic initiatives
6.4.10. Klarisana Health
6.4.10.1. Overview
6.4.10.2. Financial performance
6.4.10.3. Service benchmarking
6.4.10.4. Strategic initiatives
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. U.S. ketamine clinics market revenue estimates and forecast, by treatment, 2018 - 2030 (USD Million)
Table 4. U.S. ketamine clinics market revenue estimates and forecast, by therapy, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 U.S. ketamine clinics market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market snapshot
Fig. 10 Treatment & therapy segment outlook
Fig. 11 Competitive landscape
Fig. 12 U.S. ketamine clinics market: Market dynamics
Fig. 13 U.S. ketamine clinics market: Porter’s analysis
Fig. 14 U.S. ketamine clinics market: PESTLE analysis
Fig. 15 U.S. ketamine clinics market: Treatment segment dashboard
Fig. 16 U.S. ketamine clinics market: Treatment movement share analysis
Fig. 17 Depression market, 2018 - 2030 (USD Million)
Fig. 18 Anxiety market, 2018 - 2030 (USD Million)
Fig. 19 PTSD market, 2018 - 2030 (USD Million)
Fig. 20 Others market, 2018 - 2030 (USD Million)
Fig. 21 U.S. ketamine clinics market: Therapy segment dashboard
Fig. 22 U.S. ketamine clinics market: Therapy movement share analysis
Fig. 23 On-site therapy market, 2018 - 2030 (USD Million)
Fig. 24 Online therapy market, 2018 - 2030 (USD Million)
Fig. 25 Company categorization
Fig. 26 Company market position analysis
Fig. 27 Strategic framework